Aarhus University Seal / Aarhus Universitets segl

Kirsten Bouchelouche

Detection of Lymph Node Metastasis in Patients with Bladder Cancer using Maximum Standardised Uptake Value and 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography: Results from a High-volume Centre Including Long-term Follow-up

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

Standard

Harvard

APA

CBE

MLA

Vancouver

Author

Bibtex

@article{aec0c7b7fa4d49448afa8e2b2c9f6b25,
title = "Detection of Lymph Node Metastasis in Patients with Bladder Cancer using Maximum Standardised Uptake Value and 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography: Results from a High-volume Centre Including Long-term Follow-up",
abstract = "Background: Preoperative staging with 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET) combined with computed tomography (CT) is used for the evaluation of metastatic disease in patients with invasive bladder cancer. The use of quantification with maximum standardized uptake value (SUVmax) of regional lymph nodes (LNs) has been suggested to increase the diagnostic ability for detection of malignancy. Objective: Assessment of the utility and clinical relevance of SUVmax in 18F-FDG PET in detecting regional nodal metastases in patients considered for radical cystectomy. Design, setting, and participants: From 2011 to 2014, we identified a total of 119 patients with urothelial carcinoma who underwent radical cystectomy with extended LN dissection; additionally, 12 patients were identified by preoperative biopsy. All patients underwent 18F-FDG PET/CT before treatment recommendation. Pathological findings were compared with preoperative PET/CT staging and analysed in a regional- or patient-based model according to SUVmax values. Outcome measurements and statistical analysis: In total, 2291 LNs were identified in 131 patients; locoregional involvement of 85 LNs were confirmed in 34 patients. Results and limitations: SUVmax >2 analysis: sensitivity. ±. 95% confidence interval of 79.4% (62.1-91.3) and specificity 66.5% (55.7-75.3). SUVmax >4 based analysis: sensitivity was 61.8% (43.6-77.8) and specificity was 84.5% (75.8-91.1). Two years of follow-up implied that higher SUVmax is correlated with higher recurrence risk, independent of conventional pathological findings. Conclusions: 18F-FDG PET/CT using SUVmax of LNs is a useful tool for preoperative evaluation of pelvic LN metastases from invasive bladder cancer and contributes to the selection of patients for personalized treatment. Patient summary: In this report, we establish that it is possible to identify disease from bladder cancer in the lymphatic tissue surrounding the bladder using a scan analysis. This assists in the selection of treatment for patients with bladder cancer and may spare patients from unnecessary procedures. In this report, we found that 18F-fluorodeoxyglucose positron emission tomography/computed tomography is able to identify metastatic disease in regional lymph nodes in bladder cancer patients. The use of maximum standardized uptake values improve the evaluation of lymph nodes prior to treatment.",
keywords = "FDG-PET/CT, Fluorodeoxyglucose F18, Invasive bladder cancer, Lymph node staging, PET-CT",
author = "Stefan Vind-Kezunovic and Kirsten Bouchelouche and Pia Ipsen and S{\o}ren H{\o}yer and Cathrine Bell and {Bjerggaard Jensen}, J{\o}rgen",
year = "2019",
month = jan,
doi = "10.1016/j.euf.2017.06.005",
language = "English",
volume = "5",
pages = "90--96",
journal = "European Urology Focus",
issn = "2405-4569",
publisher = "Elsevier BV",
number = "1",

}

RIS

TY - JOUR

T1 - Detection of Lymph Node Metastasis in Patients with Bladder Cancer using Maximum Standardised Uptake Value and 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography

T2 - Results from a High-volume Centre Including Long-term Follow-up

AU - Vind-Kezunovic, Stefan

AU - Bouchelouche, Kirsten

AU - Ipsen, Pia

AU - Høyer, Søren

AU - Bell, Cathrine

AU - Bjerggaard Jensen, Jørgen

PY - 2019/1

Y1 - 2019/1

N2 - Background: Preoperative staging with 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET) combined with computed tomography (CT) is used for the evaluation of metastatic disease in patients with invasive bladder cancer. The use of quantification with maximum standardized uptake value (SUVmax) of regional lymph nodes (LNs) has been suggested to increase the diagnostic ability for detection of malignancy. Objective: Assessment of the utility and clinical relevance of SUVmax in 18F-FDG PET in detecting regional nodal metastases in patients considered for radical cystectomy. Design, setting, and participants: From 2011 to 2014, we identified a total of 119 patients with urothelial carcinoma who underwent radical cystectomy with extended LN dissection; additionally, 12 patients were identified by preoperative biopsy. All patients underwent 18F-FDG PET/CT before treatment recommendation. Pathological findings were compared with preoperative PET/CT staging and analysed in a regional- or patient-based model according to SUVmax values. Outcome measurements and statistical analysis: In total, 2291 LNs were identified in 131 patients; locoregional involvement of 85 LNs were confirmed in 34 patients. Results and limitations: SUVmax >2 analysis: sensitivity. ±. 95% confidence interval of 79.4% (62.1-91.3) and specificity 66.5% (55.7-75.3). SUVmax >4 based analysis: sensitivity was 61.8% (43.6-77.8) and specificity was 84.5% (75.8-91.1). Two years of follow-up implied that higher SUVmax is correlated with higher recurrence risk, independent of conventional pathological findings. Conclusions: 18F-FDG PET/CT using SUVmax of LNs is a useful tool for preoperative evaluation of pelvic LN metastases from invasive bladder cancer and contributes to the selection of patients for personalized treatment. Patient summary: In this report, we establish that it is possible to identify disease from bladder cancer in the lymphatic tissue surrounding the bladder using a scan analysis. This assists in the selection of treatment for patients with bladder cancer and may spare patients from unnecessary procedures. In this report, we found that 18F-fluorodeoxyglucose positron emission tomography/computed tomography is able to identify metastatic disease in regional lymph nodes in bladder cancer patients. The use of maximum standardized uptake values improve the evaluation of lymph nodes prior to treatment.

AB - Background: Preoperative staging with 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET) combined with computed tomography (CT) is used for the evaluation of metastatic disease in patients with invasive bladder cancer. The use of quantification with maximum standardized uptake value (SUVmax) of regional lymph nodes (LNs) has been suggested to increase the diagnostic ability for detection of malignancy. Objective: Assessment of the utility and clinical relevance of SUVmax in 18F-FDG PET in detecting regional nodal metastases in patients considered for radical cystectomy. Design, setting, and participants: From 2011 to 2014, we identified a total of 119 patients with urothelial carcinoma who underwent radical cystectomy with extended LN dissection; additionally, 12 patients were identified by preoperative biopsy. All patients underwent 18F-FDG PET/CT before treatment recommendation. Pathological findings were compared with preoperative PET/CT staging and analysed in a regional- or patient-based model according to SUVmax values. Outcome measurements and statistical analysis: In total, 2291 LNs were identified in 131 patients; locoregional involvement of 85 LNs were confirmed in 34 patients. Results and limitations: SUVmax >2 analysis: sensitivity. ±. 95% confidence interval of 79.4% (62.1-91.3) and specificity 66.5% (55.7-75.3). SUVmax >4 based analysis: sensitivity was 61.8% (43.6-77.8) and specificity was 84.5% (75.8-91.1). Two years of follow-up implied that higher SUVmax is correlated with higher recurrence risk, independent of conventional pathological findings. Conclusions: 18F-FDG PET/CT using SUVmax of LNs is a useful tool for preoperative evaluation of pelvic LN metastases from invasive bladder cancer and contributes to the selection of patients for personalized treatment. Patient summary: In this report, we establish that it is possible to identify disease from bladder cancer in the lymphatic tissue surrounding the bladder using a scan analysis. This assists in the selection of treatment for patients with bladder cancer and may spare patients from unnecessary procedures. In this report, we found that 18F-fluorodeoxyglucose positron emission tomography/computed tomography is able to identify metastatic disease in regional lymph nodes in bladder cancer patients. The use of maximum standardized uptake values improve the evaluation of lymph nodes prior to treatment.

KW - FDG-PET/CT

KW - Fluorodeoxyglucose F18

KW - Invasive bladder cancer

KW - Lymph node staging

KW - PET-CT

UR - http://www.scopus.com/inward/record.url?scp=85021129050&partnerID=8YFLogxK

U2 - 10.1016/j.euf.2017.06.005

DO - 10.1016/j.euf.2017.06.005

M3 - Journal article

C2 - 28753817

AN - SCOPUS:85021129050

VL - 5

SP - 90

EP - 96

JO - European Urology Focus

JF - European Urology Focus

SN - 2405-4569

IS - 1

ER -